Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Systematic Review of the Efficacy and Toxicity of Brachytherapy Boost Combined with External Beam Radiotherapy for Nonmetastatic Prostate Cancer.
Slevin F, Zattoni F, Checcucci E, Cumberbatch MGK, Nacchia A, Cornford P, Briers E, De Meerleer G, De Santis M, Eberli D, Gandaglia G, Gillessen S, Grivas N, Liew M, Linares Espinós EE, Oldenburg J, Oprea-Lager DE, Ploussard G, Rouvière O, Schoots IG, Smith EJ, Stranne J, Tilki D, Smith CT, Van Den Bergh RCN, Van Oort IM, Wiegel T, Yuan CY, Van den Broeck T, Henry AM. Slevin F, et al. Eur Urol Oncol. 2023 Dec 26:S2588-9311(23)00284-5. doi: 10.1016/j.euo.2023.11.018. Online ahead of print. Eur Urol Oncol. 2023. PMID: 38151440 Free article. Review.
Outcomes of radiosensitisation in elderly patients with advanced bladder cancer.
Christodoulou M, Reeves KJ, Hodgson C, Zeniou A, Slevin F, Kennedy J, Hoskin PJ, Henry A, Choudhury A. Christodoulou M, et al. Among authors: slevin f. Radiother Oncol. 2018 Dec;129(3):499-506. doi: 10.1016/j.radonc.2018.05.022. Epub 2018 Jun 2. Radiother Oncol. 2018. PMID: 29871812 Free article. Clinical Trial.
A comparison of outcomes for patients with intermediate and high risk prostate cancer treated with low dose rate and high dose rate brachytherapy in combination with external beam radiotherapy.
Slevin F, Rodda SL, Bownes P, Murray L, Bottomley D, Wilkinson C, Adiotomre E, Al-Qaisieh B, Dugdale E, Hulson O, Mason J, Smith J, Henry AM. Slevin F, et al. Clin Transl Radiat Oncol. 2019 Oct 14;20:1-8. doi: 10.1016/j.ctro.2019.10.001. eCollection 2020 Jan. Clin Transl Radiat Oncol. 2019. PMID: 31701035 Free PMC article.
Response to 'Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer'.
Slevin F, Rodda SL, Bownes P, Murray L, Bottomley D, Melody C, Adiotomre E, Al-Qaisieh B, Dugdale E, Hulson O, Mason J, Smith J, Henry AM. Slevin F, et al. Clin Transl Radiat Oncol. 2020 Jun 10;24:52. doi: 10.1016/j.ctro.2020.06.001. eCollection 2020 Sep. Clin Transl Radiat Oncol. 2020. PMID: 32637660 Free PMC article. No abstract available.
An international Delphi consensus for pelvic stereotactic ablative radiotherapy re-irradiation.
Slevin F, Aitken K, Alongi F, Arcangeli S, Chadwick E, Chang AR, Cheung P, Crane C, Guckenberger M, Jereczek-Fossa BA, Kamran SC, Kinj R, Loi M, Mahadevan A, Massaccesi M, Mendez LC, Muirhead R, Pasquier D, Pontoriero A, Spratt DE, Tsang YM, Zelefsky MJ, Lilley J, Dickinson P, Hawkins MA, Henry AM, Murray LJ. Slevin F, et al. Radiother Oncol. 2021 Nov;164:104-114. doi: 10.1016/j.radonc.2021.09.010. Epub 2021 Sep 21. Radiother Oncol. 2021. PMID: 34560186
33 results